Suppr超能文献

二氧化铈-氮杂冠醚共轭物作为联合放射性药物的纳米平台

CeO-Azacrown Conjugate as a Nanoplatform for Combined Radiopharmaceuticals.

作者信息

Khabirova Sofia, Aleshin Gleb, Plakhova Tatiana, Zubenko Anastasia, Shchukina Anna, Fedorova Olga, Averin Aleksey, Belova Ekaterina, Bazarkina Elena, Kvashnina Kristina, Kalmykov Stepan

机构信息

Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory, 1/3, 119991 Moscow, Russia.

N. Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences, Vavilova, 28, GSP-1, 119991 Moscow, Russia.

出版信息

Nanomaterials (Basel). 2022 Dec 18;12(24):4484. doi: 10.3390/nano12244484.

Abstract

This study is one of the first attempts to assess CeO nanoparticles as a nanoplatform for radiopharmaceuticals with radionuclides. The process of functionalization using a bifunctional azacrown ligand is described, and the resulting conjugates are characterized by IR and Raman spectroscopy. Their complexes with Bi show a high stability in medically relevant media, thus encouraging the further study of these conjugates in vivo as potential combined radiopharmaceuticals.

摘要

本研究是最早尝试将CeO纳米颗粒评估为含放射性核素放射性药物的纳米平台之一。描述了使用双功能氮杂冠醚配体的功能化过程,所得共轭物通过红外光谱和拉曼光谱进行表征。它们与铋的配合物在医学相关介质中显示出高稳定性,因此鼓励进一步研究这些共轭物在体内作为潜在的联合放射性药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/561e/9783244/427106ecc6cb/nanomaterials-12-04484-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验